Survival analysis also showed that pretreated CK18-positive tumours were also significantly associated with poorer OS than biopsy CK18-negative ones (5-year OS: 30.4% vs 62.2%, respectively, P=0.045) (Figure 5). This evidence concerns the gene KRT18 and neoplasm.